Gene · 1241
Papers1,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LC-MS/MS-Based Serum Metabolomics and Transcriptome Analyses for the Mechanism of Augmented Renal Clearance. | Int J Mol Sci | 2023 | 37445637 | PubTator, text mining | PubMed |
| Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development. | Diagnostics (Basel) | 2023 | 37443631 | PubTator, text mining | PubMed |
| Lipoxin receptor agonist and inhibition of LTA4 hydrolase prevent tight junction disruption caused by P. aeruginosa filtrate in airway epithelial cells. | PLoS One | 2023 | 37406028 | PubTator, text mining | PubMed |
| Appearance of tuft cells during prostate cancer progression. | Oncogene | 2023 | 37386128 | PubTator, text mining | PubMed |
| Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity. | Int J Mol Sci | 2023 | 37372966 | PubTator, text mining | PubMed |
| Silencing of TRAF5 enhances necroptosis in hepatocellular carcinoma by inhibiting LTBR-mediated NF-κB signaling. | PeerJ | 2023 | 37366426 | PubTator, text mining | PubMed |
| The pro-resolving lipid mediator Maresin 1 ameliorates pain responses and neuroinflammation in the spared nerve injury-induced neuropathic pain: A study in male and female mice. | PLoS One | 2023 | 37347750 | PubTator, text mining | PubMed |
| Lipid metabolism and rheumatoid arthritis. | Front Immunol | 2023 | 37325667 | PubTator, text mining | PubMed |
| Pro- and Anti-Inflammatory Prostaglandins and Cytokines in Humans: A Mini Review. | Int J Mol Sci | 2023 | 37298597 | PubTator, text mining | PubMed |
| Insights into the epigenetics of chronic rhinosinusitis with and without nasal polyps: a systematic review. | Front Allergy | 2023 | 37284022 | PubTator, text mining | PubMed |
| Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84. | Nat Commun | 2023 | 37277332 | PubTator, text mining | PubMed |
| The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy. | Acta Pharm Sin B | 2023 | 37250161 | PubTator, text mining | PubMed |
| Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators-a review. | Int J Immunopathol Pharmacol | 2023 | 37246293 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of Marine Lissodendrins B Analogues as Modulators of ABCB1-Mediated Multidrug Resistance. | Mar Drugs | 2023 | 37233508 | PubTator, text mining | PubMed |
| Multi-omics profiling approach in food allergy. | World Allergy Organ J | 2023 | 37214173 | PubTator, text mining | PubMed |
| Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics. | Bioimpacts | 2023 | 37193075 | PubTator, text mining | PubMed |
| Cyclooxygenase and Lipoxygenase Gene Expression in the Inflammogenesis of Colorectal Cancer: Correlated Expression of EGFR, JAK STAT and Src Genes, and a Natural Antisense Transcript, RP11-C67.2.2. | Cancers (Basel) | 2023 | 37190308 | PubTator, text mining | PubMed |
| Immune landscape of breast tumors with low and intermediate estrogen receptor expression. | NPJ Breast Cancer | 2023 | 37179445 | PubTator, text mining | PubMed |
| Crosstalk between macrophages and cardiac cells after myocardial infarction. | Cell Commun Signal | 2023 | 37170235 | PubTator, text mining | PubMed |
| Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's disease. | Commun Med (Lond) | 2023 | 37165152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1241/papers?page=6